All In Biotech

Drug Trial Radar · NCT06109818

Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients with Moderate to Severe Plaque Psoriasis

A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of ICP-488 in Patients with Moderate to Severe Plaque Psoriasis

Last checked: Nov 19, 2026Latest source record: Feb 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 129 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

129

Actual

Start

Jan 4, 2024

Primary completion

Aug 5, 2024

Study completion Sep 18, 2024

Sponsor

Sponsor type
Industry
First posted
Oct 31, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical study to evaluate ICP-488.Efficacy, safety, PK, and PD characteristics in Chinese adults with moderate to severe plaque psoriasis.

Conditions

  • Moderate to Severe Plaque Psoriasis

Interventions

  • ICP-488 TabletsDrug

    ICP-488 will be administered as tablet

  • ICP-488 PlaceboDrug

    ICP-488 Placebo will be administered as tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of subjects who achieved a PASI 75 response (a reduction of minimum 75% from baseline in PASI score) at Week 12.Time frame: Baseline up to Week 12

Locations

31 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing Friendship Hospital, Capital Medical University

    Beijing, Beijing Municipality, China

  • China-Japan Friendship Hospital

    Beijing, Beijing Municipality, China

  • The First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China

  • The First Affiliated Hospital of Fujian Medical University

    Fuzhou, Fujian, China

  • Dermatology Hospital of Southern Medical University

    Guangzhou, Guangdong, China

  • Guangdong Hospital of Traditional Chinese Medicine

    Guangzhou, Guangdong, China

  • Affiliated Hospital of Guizhou Medical University

    Guiyang, Guizhou, China

  • The Affiliated Hospital of Chengde Medical College

    Chengde, Hebei, China

  • The first hospital of hebei medical university

    Shijiazhuang, Hebei, China

  • The Second Affiliated Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China

  • Nanyang city first People's Hospital

    Nanyang, Henan, China

  • Henan Provincial People's Hospital

    Zhengzhou, Henan, China

  • Shiyan City People's Hospital

    Shiyan, Hubei, China

  • Wuhan University People's Hospital

    Wuhan, Hubei, China

  • Wuhan No.1 hospital

    Wuhan, Hubei, China

  • Xiangya hospital central south university

    Changsha, Hunan, China

  • Affiliated Hospital of Inner Mongolia Medical University

    Hohhot, Inner Mongolia, China

  • Changzhou First People's Hospital

    Changzhou, Jiangsu, China

  • Lianyungang First People's Hospital

    Lianyungang, Jiangsu, China

  • Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of medical Sciences, Peking Union Medical College

    Nanjing, Jiangsu, China

  • First Hospital of Jilin University

    Changchun, Jilin, China

  • Mei he kou central hospital

    Meihekou, Jilin, China

  • Central Hospital affiliated to shandong first medical unversity

    Jinan, Shandong, China

  • Shanghai Dermatology Hospital

    Shanghai, Shanghai Municipality, China

  • Huashan Hospital Affiliated to Fudan University

    Shanghai, Shanghai Municipality, China

  • Chengdu Second People's Hospital

    Chengdu, Sichuan, China

  • The First Affiliated Hospital of Kunming Medical University

    Kunming, Yunnan, China

  • Hangzhou First People's Hospital

    Hangzhou, Zhejiang, China

  • Zhejiang Provincial People's Hospital

    Hangzhou, Zhejiang, China

  • The First Hospital of Jiaxing

    Jiaxing, Zhejiang, China

  • The First Affiliated Hospital of Wenzhou Medical University

    Wenzhou, Zhejiang, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.